Pengaruh Tiga Jenis Pupuk Kandang Terhadap Pertumbuhan Dan Produksi Tanaman Cabai (Capssicum Annum L.) Yang Dipupuk Kcl Dengan Berbagai Dosis

Penelitian dilakukan untuk mengetahui jenis pupuk kandang yang memberikan pengaruh terbaik pada pertumbuhan dan produksi tanaman cabai, dosis pupuk KCl yang memberikan pengaruh terbaik pada pertumbuhan dan produksi tanaman cabai, dan pengaruh interaksi antara jenis pupuk kandang dan dosis pupuk KCl terhadap pertumbuhan dan produksi tanaman cabai. Penelitian dilaksanakan dari bulan Juni sampai Oktober 2012 di kebun percobaan Universitas Lampung. Perlakuan disusun dalam rancangan acak kelompok (RAK) pola faktorial (3x5) dengan tiga ulangan. Faktor pertama yaitu jenis pupuk kandang (pupuk kandang sapi, pupuk kandang kambing, pupuk kandang ayam). Faktor kedua yaitu dosis pupuk KCl (0 kg ha-1, 50 kg ha-1, 100 kg ha-1, 150 kg ha-1, dan 200 kg ha-1). Data dianalisis dengan ragam dan dilanjutkan dengan uji polinomial orthogonal. Hasil penelitian menunjukkan bahwa pupuk kandang ayam memberikan pengaruh yang lebih baik dibandingkan dengan pupuk kandang sapi dan pupuk kandang kambing pada pertumbuhan dan produksi tanaman cabai, taraf dosis pupuk KCl hingga 200 kg ha-1 berpengaruh pada tinggi tanaman, tingkat percabangan, jumlah bunga, jumlah buah, diameter buah, panjang buah, dan bobot kering berangkasan tanaman secara linear, dan terdapat pengaruh interaksi antara jenis pupuk kandang ayam dengan dosis pupuk KCl 0 kg ha-1, 50 kg ha-1, 100 kg ha-1, dan 150 kg ha-1 pada tingkat percabangan, jumlah buah, diameter buah, panjang buah, dan bobot kering brangkasan

Potensi Alang-alang (Imperata Cylindrica (L.) Beauv) dalam Produksi Etanol Menggunakan Bakteri Zymomonas Mobilis

Sumber selulosa yang murah dan melimpah dapat diperoleh dari gulma alang-alang (Imperata cylindrica (L.) Beauv). Produksi etanol dari bahan baku selulosa alang-alang umumnya difermentasikan oleh yeast. Pada penelitian ini fermentasi dilakukan menggunakan bakteri Zymomonas mobilis. Penelitian dilakukan pada bulan November 2012 hingga Mei 2013 di laboratorium Jurusan Biologi, Fakultas Matematika dan Ilmu Pengetahuan Alam, ITS. Penelitian bertujuan untuk mengetahui potensi alang-alang (I. cylindrica (L) Beauv.) dalam produksi etanol menggunakan bakteri Z. mobilis pada konsentrasi inokulum dan waktu fermentasi yang optimum. Penelitian ini dilakukan dalam tiga langkah utama yaitu pretreatment substrat, hidrolisis enzimatik oleh Penicillium sp., dan fermentasi etanol oleh Z. mobilis. Fermentasi dilakukan menggunakan berbagai perlakuan konsentrasi inokulum (0, 5, 10, dan 15%) dan lama fermentasi (0, 3, 5, 7, dan 9 days) serta dianalisa menggunakan uji Analysis of Varians (ANOVA). Masing-masing perlakuan dilakuan 2 kali pengulangan, sehingga diperoleh 40 unit percobaan dengan parameter yang diamati adalah kadar etanol. Hasil penelitian menunjukkan bahwa alang-alang (I. cylindrica (L.) Beauv.) berpotensi untuk dijadikan sebagai bahan baku produksi etanol dengan konsentrasi etanol tertinggi diperoleh dari interaksi antara 10% konsentrasi inokulum Z. mobilis dan waktu fermentasi 7 hari yaitu sebesar 9,02 % (v/v

Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder

Selective serotonin reuptake inhibitors have proven efficacy in the treatment of panic disorder, obsessive–compulsive disorder, post-traumatic stress disorder and social anxiety disorder. Accumulating data shows that selective serotonin reuptake inhibitor treatment can also be efficacious in patients with generalized anxiety disorder. This review summarizes the findings of randomized controlled trials of selective serotonin reuptake inhibitor treatment for generalized anxiety disorder, examines the strengths and weaknesses of other therapeutic approaches and considers potential new treatments for patients with this chronic and disabling anxiety disorder

Physical health behaviours and health locus of control in people with schizophrenia-spectrum disorder and bipolar disorder: a cross-sectional comparative study with people with non-psychotic mental illness

<p>Abstract</p> <p>Background</p> <p>People with mental illness experience high levels of morbidity and mortality from physical disease compared to the general population. Our primary aim was to compare how people with severe mental illness (SMI; i.e. schizophrenia-spectrum disorders and bipolar disorder) and non-psychotic mental illness perceive their: (i) global physical health, (ii) barriers to improving physical health, (iii) physical health with respect to important aspects of life and (iv) motivation to change modifiable high-risk behaviours associated with coronary heart disease. A secondary aim was to determine health locus of control in these two groups of participants.</p> <p>Methods</p> <p>People with SMI and non-psychotic mental illness were recruited from an out-patient adult mental health service in London. Cross-sectional comparison between the two groups was conducted by means of a self-completed questionnaire.</p> <p>Results</p> <p>A total of 146 people participated in the study, 52 with SMI and 94 with non-psychotic mental illness. There was no statistical difference between the two groups with respect to the perception of global physical health. However, physical health was considered to be a less important priority in life by people with SMI (OR 0.5, 95% CI 0.2-0.9, <it>p </it>= 0.029). There was no difference between the two groups in their desire to change high risk behaviours. People with SMI are more likely to have a health locus of control determined by powerful others (<it>p </it>< 0.001) and chance (<it>p </it>= 0.006).</p> <p>Conclusions</p> <p>People with SMI appear to give less priority to their physical health needs. Health promotion for people with SMI should aim to raise awareness of modifiable high-risk lifestyle factors. Findings related to locus of control may provide a theoretical focus for clinical intervention in order to promote a much needed behavioural change in this marginalised group of people.</p

Exploring the similarities and differences between medical assessments of competence and criminal responsibility

The medical assessments of criminal responsibility and competence to consent to treatment are performed, developed and debated in distinct domains. In this paper I try to connect these domains by exploring the similarities and differences between both assessments. In my view, in both assessments a decision-making process is evaluated in relation to the possible influence of a mental disorder on this process. I will argue that, in spite of the relevance of the differences, both practices could benefit from the recognition of this similarity. For cooperative research could be developed directed at elucidating exactly how various mental disturbances can affect decision-making processes

Comorbid substance abuse and brain morphology in recent-onset psychosis

The aim of the presented study was to compare schizophrenia and schizoaffective patients early in the course of the disease with and without comorbid substance abuse disorder (SUD vs. NSUD) with regard to brain morphology. In a prospective design 41 patients (20 SUD vs. 21 NSUD) diagnosed as recent-onset schizophrenia or schizoaffective disorder consecutively admitted to hospital received standardized psychopathological evaluation (BPRS, SANS, MADRS, CGI, GAF) and MRI scanning with volumetric measurement of superior temporal gyrus (STG), amygdala-hippocampal complex, and cingulum. Patients with SUD (primarily cannabis) were significantly younger, predominantly male and had a lower socioeconomic status. Despite less attentional impairment (SANS subscore) and elevated anxiety/depression (BPRS subscore) in patients with SUD compared to NSUD, no other psychopathological differences could be detected. There were no differences in the assessed temporolimbic brain morphology between the two subgroups. In conclusion, in this study substance abuse in recent-onset psychosis had no effect on brain morphology and the earlier onset of psychosis in patients with comorbid SUD could not be explained by supposed accentuated brain abnormalities in temporolimbic regions

Plasticity in bilateral superior temporal cortex: effects of deafness and cochlear implantation on auditory and visual speech processing

While many individuals can benefit substantially from cochlear implantation, the ability to perceive and understand auditory speech with a cochlear implant (CI) remains highly variable amongst adult recipients. Importantly, auditory performance with a CI cannot be reliably predicted based solely on routinely obtained information regarding clinical characteristics of the CI candidate. This review argues that central factors, notably cortical function and plasticity, should also be considered as important contributors to the observed individual variability in CI outcome. Superior temporal cortex (STC), including auditory association areas, plays a crucial role in the processing of auditory and visual speech information. The current review considers evidence of cortical plasticity within bilateral STC, and how these effects may explain variability in CI outcome. Furthermore, evidence of audio-visual interactions in temporal and occipital cortices is examined, and relation to CI outcome is discussed. To date, longitudinal examination of changes in cortical function and plasticity over the period of rehabilitation with a CI has been restricted by methodological challenges. The application of functional near-infrared spectroscopy (fNIRS) in studying cortical function in CI users is becoming increasingly recognised as a potential solution to these problems. Here we suggest that fNIRS offers a powerful neuroimaging tool to elucidate the relationship between audio-visual interactions, cortical plasticity during deafness and following cochlear implantation, and individual variability in auditory performance with a CI

The effects of Δ9-tetrahydrocannabinol on the dopamine system

Δ(9)-tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, is a pressing concern to global mental health. Patterns of use are changing drastically due to legalisation, availability of synthetic analogues (‘spice’), cannavaping and aggrandizements in the purported therapeutic effects of cannabis. Many of THC’s reinforcing effects are mediated by the dopamine system. Due to complex cannabinoid-dopamine interactions there is conflicting evidence from human and animal research fields. Acute THC causes increased dopamine release and neuron activity, whilst long-term use is associated with blunting of the dopamine system. Future research must examine the long-term and developmental dopaminergic effects of the drug

A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment

This paper is a personal account on the discovery and characterization of the 5-HT2C receptor (first known as the 5- HT1C receptor) over 30 years ago and how it translated into a number of unsuspected features for a G protein-coupled receptor (GPCR) and a diversity of clinical applications. The 5-HT2C receptor is one of the most intriguing members of the GPCR superfamily. Initially referred to as 5-HT1CR, the 5-HT2CR was discovered while studying the pharmacological features and the distribution of [3H]mesulergine-labelled sites, primarily in the brain using radioligand binding and slice autoradiography. Mesulergine (SDZ CU-085), was, at the time, best defined as a ligand with serotonergic and dopaminergic properties. Autoradiographic studies showed remarkably strong [3H]mesulergine-labelling to the rat choroid plexus. [3H]mesulergine-labelled sites had pharmacological properties different from, at the time, known or purported 5-HT receptors. In spite of similarities with 5-HT2 binding, the new binding site was called 5-HT1C because of its very high affinity for 5-HT itself. Within the following 10 years, the 5-HT1CR (later named 5- HT2C) was extensively characterised pharmacologically, anatomically and functionally: it was one of the first 5-HT receptors to be sequenced and cloned. The 5-HT2CR is a GPCR, with a very complex gene structure. It constitutes a rarity in theGPCR family: many 5-HT2CR variants exist, especially in humans, due to RNA editing, in addition to a few 5-HT2CR splice variants. Intense research led to therapeutically active 5-HT2C receptor ligands, both antagonists (or inverse agonists) and agonists: keeping in mind that a number of antidepressants and antipsychotics are 5- HT2CR antagonists/inverse agonists. Agomelatine, a 5-HT2CR antagonist is registered for the treatment of major depression. The agonist Lorcaserin is registered for the treatment of aspects of obesity and has further potential in addiction, especially nicotine/ smoking. There is good evidence that the 5-HT2CR is involved in spinal cord injury-induced spasms of the lower limbs, which can be treated with 5-HT2CR antagonists/inverse agonists such as cyproheptadine or SB206553. The 5-HT2CR may play a role in schizophrenia and epilepsy. Vabicaserin, a 5-HT2CR agonist has been in development for the treatment of schizophrenia and obesity, but was stopped. As is common, there is potential for further indications for 5-HT2CR ligands, as suggested by a number of preclinical and/or genome-wide association studies (GWAS) on depression, suicide, sexual dysfunction, addictions and obesity. The 5-HT2CR is clearly affected by a number of established antidepressants/antipsychotics and may be one of the culprits in antipsychotic-induced weight gain